Drug Eluting Balloons（DEB）Market is expected to be around US$ 3125 Million by 2028 at a CAGR of 27.0% in the given forecast period.
Developing geriatric populace and rising rate of peripheral artery diseases (PAD) globally are key point driving the growth for drug eluting balloon market. The interest for compelling treatments focusing on signs, for example, in-stent restenosis and complex sores, and decreasing entanglements related with drug-eluting stenting (DES), will be essential drivers behind the market growth. Downstream cost-sparing measures are likewise expected to contribute, alongside an expanding commonness in CAD and PAD.
Drug-eluting balloons (DEB) are customary semi-consistent angioplasty inflatables secured with an enemy of proliferative medication which is discharged into the vessel divider during the expansion of the inflatable, generally at ostensible weights with a particular negligible swelling time. The dynamic substance on the DEB ought to be lipophilic enough to have a high retention rate through the vessel divider to make up for the brief time of contact between the swelled inflatable and the vessel divider itself and to keep up a continued impact once discharged.
The global Drug Eluting Balloons （DEB） market is segregated on the basis of Product as SeQuent Please Balloons, In.Pact Falcon Balloons, Paccocath Balloons, and DIOR Balloons. Based on End-User the global Drug Eluting Balloons （DEB） market is segmented in Peripheral Artery Diseases, Obesity and Diabetes, Coronary Artery Diseases, and Others.
The global Drug Eluting Balloons （DEB） market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Drug Eluting Balloons （DEB） market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Eurocor, Cook Medical, Terumo Corporation, Becton, Dickinson and Company, Medtronic Plc, C.R. Bard, Medtronic, Aachen Resonance, Bayer, B.Braun Melsungen, and others are among the major players in the global Drug Eluting Balloons （DEB） market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drug Eluting Balloons (DEB) Market has been segmented as below:
Drug Eluting Balloons (DEB) Market, By Product
Drug Eluting Balloons (DEB) Market, By End-User
Drug Eluting Balloons (DEB) Market, By Region
Drug Eluting Balloons (DEB) Market, By Company
The report covers:
Report Scope:
The global Drug Eluting Balloons （DEB） market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics.
The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Drug Eluting Balloons （DEB） market share. Major industry players with significant revenue share include Eurocor, Cook Medical, Terumo Corporation, Becton, Dickinson and Company, Medtronic Plc, C.R. Bard, Medtronic, Aachen Resonance, Bayer, B.Braun Melsungen, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Tick-borne Encephalitis Vaccine market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Drug Eluting Balloons （DEB） Market, By Product
5.1 Introduction
5.2 SeQuent Please Balloons
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 In.Pact Falcon Balloons
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Paccocath Balloons
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 DIOR Balloons
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Drug Eluting Balloons （DEB） Market, By End-User
6.1 Introduction
6.2 Peripheral Artery Diseases
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Obesity and Diabetes
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Coronary Artery Diseases
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Drug Eluting Balloons （DEB） Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Drug Eluting Balloons （DEB）, By Product
7.2.2 North America Drug Eluting Balloons （DEB）, By End-User
7.3 Europe
7.3.1 Europe Drug Eluting Balloons （DEB）, By Product
7.3.2 Europe Drug Eluting Balloons （DEB）, By End-User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Drug Eluting Balloons （DEB）, By Product
7.4.2 Asia-Pacific Drug Eluting Balloons （DEB）, By End-User
7.5 Rest of the World
7.5.1 Rest of the World Drug Eluting Balloons （DEB）, By Product
7.5.2 Rest of the World Drug Eluting Balloons （DEB）, By End-User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Eurocor
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Cook Medical
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Terumo Corporation
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Medtronic Plc
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 C.R. Bard
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Medtronic
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Aachen Resonance
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Bayer
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 B.Braun Melsungen
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Drug Eluting Balloons (DEB) Market has been segmented as below:
Drug Eluting Balloons (DEB) Market, By Product
Drug Eluting Balloons (DEB) Market, By End-User
Drug Eluting Balloons (DEB) Market, By Region
Drug Eluting Balloons (DEB) Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
